POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,368 | +35.2% | 13,600 | 0.0% | 0.00% | – |
| Q2 2023 | $23,936 | -38.3% | 13,600 | +7.9% | 0.00% | – |
| Q1 2023 | $38,808 | -32.2% | 12,600 | +16.7% | 0.00% | – |
| Q4 2022 | $57,240 | -20.5% | 10,800 | -46.8% | 0.00% | – |
| Q3 2022 | $72,000 | +38.5% | 20,304 | 0.0% | 0.00% | – |
| Q2 2022 | $52,000 | -45.8% | 20,304 | -5.4% | 0.00% | – |
| Q1 2022 | $96,000 | -33.8% | 21,473 | +0.8% | 0.00% | – |
| Q4 2021 | $145,000 | +88.3% | 21,304 | +102.8% | 0.00% | – |
| Q3 2021 | $77,000 | -26.7% | 10,504 | 0.0% | 0.00% | – |
| Q2 2021 | $105,000 | +5.0% | 10,504 | 0.0% | 0.00% | – |
| Q1 2021 | $100,000 | – | 10,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |